PRPF31 Antikörper (C-Term)
Kurzübersicht für PRPF31 Antikörper (C-Term) (ABIN7469537)
Target
Alle PRPF31 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human PRPF31. The exact sequence is proprietary.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: NT2D1
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- PRPF31 (Pre-mRNA Processing Factor 31 (PRPF31))
-
Andere Bezeichnung
- PRPF31
-
Hintergrund
-
Synonyms: pre-mRNA processing factor 31 , NY-BR-99 , PRP31 , RP11 , SNRNP61
Background: This gene encodes a component of the spliceosome complex and is one of several retinitis pigmentosa-causing genes. When the gene product is added to the spliceosome complex, activation occurs.
-
Molekulargewicht
- 55 kDa
-
Gen-ID
- 26121
-
UniProt
- Q8WWY3
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-